Mechanodiagnostic Platform
Solid Tumors (Metastatic Risk & Therapy Guidance)
Clinical InvestigationActive
Key Facts
Indication
Solid Tumors (Metastatic Risk & Therapy Guidance)
Phase
Clinical Investigation
Status
Active
Company
About Artidis
Artidis is pioneering the integration of mechanobiology into clinical oncology diagnostics. Its core platform utilizes Atomic Force Microscopy (AFM) to quantify the physical properties of tumor cells within their native microenvironment, generating predictive biomarkers for metastatic risk and therapy response. The company is currently in the clinical investigation stage, with its technology positioned to augment standard pathology by providing same-day, actionable insights to guide chemotherapy sequencing, targeted therapies, and immunotherapy. Based in Basel, Switzerland, Artidis is a private, pre-revenue company advancing its platform through research collaborations and clinical studies.
View full company profile